Sanity Group
German cannabis distributor and CBD brand with medical and consumer focus.
Sanity Group is a real German cannabis company, but much public information about it comes from company statements rather than independent verification. Market-share claims, ownership percentages, and investor involvement are not audited by regulators. Before buying Vaay CBD products or treating company statements as fact, check lab reports, sourcing claims, and current regulatory status—these change fast in European cannabis.
What we could verify
Sanity Group GmbH is a Berlin-based cannabis company founded in 2018. It operates in two broad areas: medical cannabis supply to German pharmacies and a consumer CBD product line sold under the Vaay brand [1]. The Canadian licensed producer Organigram Holdings disclosed a minority equity stake in 2021, though exact ownership percentages are not fully public.
Sanity Group's core market is Germany, which reformed its cannabis law in 2024 (CanG), expanding medical access and partially decriminalising possession and home growing [3]. The company also participates in Switzerland's federally authorised pilot trials for regulated adult-use cannabis.
No independent regulator (German BfArM or Swiss authorities) has published public enforcement actions against Sanity Group as of October 2026, but absence of reported action is not the same as verification of compliance No data.
What the name suggests (and why that is not evidence)
You may see "Sanity Group" or "Vaay" on products labelled with claimed THC/CBD levels, strain names, terpene profiles, or effects descriptions. Cannabis strain names are not standardised or regulated, and the same name can refer to different genotypes, chemotypes and origins depending on the grower and batch Disputed. A product label or company website describing effects ("calming," "energising") is marketing language, not a clinical diagnosis Anecdote.
Brand visibility in German business press (Handelsblatt, Gründerszene) indicates that the company is known and has raised capital, but does not independently verify market share, product safety, or compliance. Company-reported figures such as "~10% of German medical cannabis market" are point-in-time estimates, not audited by German regulators Weak / limited.
What to check if you see Sanity Group products for sale
Certificate of Analysis (CoA): If buying a Vaay CBD or medical cannabis product, ask the seller or pharmacy for a third-party lab report showing:
- Actual THC and CBD content (not the label claim alone)
- Residual solvents, pesticides, microbiological contaminants Strong evidence
- Country and batch number
Sourcing and GMP status: Sanity Group distributes cannabis sourced from multiple licensed producers, not always products it cultivates itself [1]. For medical products dispensed in Germany, a pharmacy should disclose the actual manufacturer and country of origin. GMP compliance is a manufacturing standard, not a guarantee of efficacy Strong evidence.
Regulatory category: In Germany, medical cannabis is available by prescription only [3]. Vaay CBD products in the EU sit in a legal grey zone—novel-food rules for CBD ingestibles are still being defined across member states, and product claims are restricted. A product sold as "food supplement" or "cosmetic" cannot legally make medical claims, even if marketed using wellness language Strong evidence.
Ownership and funding: Sanity Group's cap table changes with each funding round. For current ownership stakes, check:
- Organigram's most recent annual filing (SEC SEDAR+ or investor relations)
- German Handelsregister (commercial register) for GmbH officers and registered owners
Swiss pilot context: The Swiss cannabis pilot trials under Article 8a are research projects, not permanent markets. Products or claims framed as "legally available in Switzerland" should be read as "available under a temporary federal research authorisation," not as evidence of a stable, long-term legal market.
Similar documented brands
Other European and international cannabis companies with comparable distributor, medical, or multi-market profiles:
- Alternaleaf (Montu) — Australian medical cannabis distributor with international expansion
- Cronos Group — Canadian licensed producer with European supply partnerships
- Aurora Cannabis — Canadian LP with medical and international focus
- Bloomwell Group — European cannabis health brand
These companies operate under different regulatory regimes and ownership structures; comparison should focus on verifiable elements (licensing, lab testing, regulatory status) rather than brand marketing.
How to report missing or incorrect information
If you have verifiable information about Sanity Group—such as a company filing, a press release with a URL, a peer-reviewed study, or a regulatory record—please flag it. We are especially interested in:
- Official company records or government filings (German Handelsregister, Organigram SEC filings, Swiss BAG pilot documentation)
- Third-party lab reports for named products
- Published regulatory actions or compliance records
- Peer-reviewed studies involving Sanity Group products or research
Unsourced claims, social-media posts, or product reviews cannot be used to update this profile. All factual updates must link to a verifiable source.
Sources
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Alternaleaf (Montu) — Alternaleaf is a UK medical cannabis telehealth clinic operated by Montu, an Australian-fo...
- Aurora Cannabis — Canadian licensed producer pivoting toward medical cannabis and international export.
- Bloomwell Group — German medical cannabis telehealth and import operator; verification status unclear.
- Cronos Group — Toronto-based public cannabis company with Altria as largest shareholder, selling adult-us...